Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Secnidazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 42Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Evofem's SOLOSEC Submitted For Regulatory Approval In The UAE
    Evofem's SOLOSEC Submitted For Regulatory Approval In The UAE

    06 Oct 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/evofems-solosec-submitted-for-regulatory-approval-in-the-uae-17945

    INDPHARMAPOST
    06 Oct 2025
    Share Share
    Evofem's SOLOSEC Data on Recurrent BV Revealed at ACOG Meeting
    Evofem's SOLOSEC Data on Recurrent BV Revealed at ACOG Meeting

    11 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/notable-data-on-evofems-solosec-in-recurrent-bacterial-vaginosis-bv-released-at-acog-annual-meeting-302478349.html

    PR NEWSWIRE
    11 Jun 2025
    Share Share
    Evofem Signs Solosec License Agreement for Middle East
    Evofem Signs Solosec License Agreement for Middle East

    22 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evofem-signs-solosec-license-agreement-for-middle-east-with-pharma-1-302461405.html

    PR NEWSWIRE
    22 May 2025
    Share Share
    Lupin divests women’s health specialty business in US to Evofem for $84 million
    Lupin divests women’s health specialty business in US to Evofem for $84 million

    15 Jul 2024

    // MONEY CONTROL

    https://www.moneycontrol.com/news/business/companies/lupin-divests-womens-health-specialty-business-in-us-to-evofem-for-84-million-12769646.html

    MONEY CONTROL
    15 Jul 2024
    Share Share
    Lupin Divests US Women's Health Specialty Business To Evofem
    Lupin Divests US Women's Health Specialty Business To Evofem

    15 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lupin-divests-us-commercial-womens-health-specialty-business-to-evofem-including-solosec-302196783.html

    PR NEWSWIRE
    15 Jul 2024
    Share Share
    Lupin’s Solosec bags FDA approval for bacterial vaginosis and trichomoniasis
    Lupin’s Solosec bags FDA approval for bacterial vaginosis and trichomoniasis

    18 Feb 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145915&sid=2

    PHARMABIZ
    18 Feb 2022
    Share Share